Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Kangji Medical Holdings Limited (DE:50J)
FRANKFURT:50J
RESEARCH TOOLSreports
Kangji Medical Holdings Limited (50J) Stock Price & Analysis
0 Followers
50J Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€0.54 - €0.79
Previous Close€0.64
Volume0.00
Average Volume (3M)840.00
Market Cap
€790.00M
Enterprise Value€446.68M
Total Cash (Recent Filing)¥3.09B
Total Debt (Recent Filing)¥48.82M
Price to Earnings (P/E)1.5
Beta0.75
Next Earnings
Aug 27, 2024EPS Estimate
€0.02Last Dividend Ex-Date
May 29, 2024Dividend Yield170%
Share Statistics
EPS (TTM)0.43
Shares Outstanding1,214,821,000
10 Day Avg. Volume0
30 Day Avg. Volume840
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Kangji Medical Holdings Limited News
PremiumCompany Announcements
Kangji Medical Announces Final Dividend for 2023PremiumCompany Announcements
Kangji Medical Declares Special Dividend
PremiumCompany Announcements
Kangji Medical Offers Dividend Currency Choice
PremiumCompany Announcements
Kangji Medical Shareholders Show Strong Support at AGMOptions Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
1.08% Mutual Funds
1.59% Other Institutional Investors
97.32% Public Companies and
Individual Investors
50J FAQ
What was Kangji Medical Holdings Limited’s price range in the past 12 months?
Kangji Medical Holdings Limited lowest stock price was €0.54 and its highest was €0.79 in the past 12 months.
What is Kangji Medical Holdings Limited’s market cap?
Currently, no data Available
When is Kangji Medical Holdings Limited’s upcoming earnings report date?
Kangji Medical Holdings Limited’s upcoming earnings report date is Aug 27, 2024 which is in 51 days.
How were Kangji Medical Holdings Limited’s earnings last quarter?
Kangji Medical Holdings Limited released its earnings results on Mar 20, 2024. The company reported €0.023 earnings per share for the quarter, missing the consensus estimate of €0.031 by -€0.007.
Is Kangji Medical Holdings Limited overvalued?
According to Wall Street analysts Kangji Medical Holdings Limited’s price is currently Overvalued.
Does Kangji Medical Holdings Limited pay dividends?
Kangji Medical Holdings Limited pays a Annually dividend of €0.05 which represents an annual dividend yield of 170%. See more information on Kangji Medical Holdings Limited dividends here
What is Kangji Medical Holdings Limited’s EPS estimate?
Kangji Medical Holdings Limited’s EPS estimate is €0.02.
How many shares outstanding does Kangji Medical Holdings Limited have?
Kangji Medical Holdings Limited has 1,214,821,000 shares outstanding.
What happened to Kangji Medical Holdings Limited’s price movement after its last earnings report?
Kangji Medical Holdings Limited reported an EPS of €0.023 in its last earnings report, missing expectations of €0.031. Following the earnings report the stock price went up 9.091%.
Which hedge fund is a major shareholder of Kangji Medical Holdings Limited?
Currently, no hedge funds are holding shares in DE:50J
---
Kangji Medical Holdings Limited Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-16.12%
12-Months-Change
Fundamentals
Return on Equity
14.35%
Trailing 12-Months
Asset Growth
7.00%
Trailing 12-Months
Company Description
Kangji Medical Holdings Limited
Kangji Medical Holdings Ltd is engaged in production and sales of minimally invasive surgical instruments and accessories. The company offers a product portfolio to provide physicians and hospitals with one-shop and tailored surgical solutions for four major surgical specialties OBGYN, general surgery, urology and thoracic surgery. It manufactures and sells both disposable and reuseable products. Its product portfolio includes disposable trocars, polymer ligation clips, Class III disposable electrocoagulation forceps, and reusable trocar and forceps. It derives majority of the revenue from Mainland China.
---
50J Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering 50J
1 Year
1 Year Success Rate
0/3 ratings generated profit
1 Year Average Return
-3.33%
reiterated a buy rating 4 months ago
Copying Chris Pan's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -3.33% per trade.
---